ArticlePharmacological reports : PR2025

MIM1 - a selective Mcl-1 protein inhibitor augments the proapoptotic activity of moxifloxacin toward MDA-MB-231 triple-negative breast cancer cells - a preliminary in vitro study.

Artur Beberok et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.